311 related articles for article (PubMed ID: 30611278)
1. Malaria parasite clearance rate regression: an R software package for a Bayesian hierarchical regression model.
Sharifi-Malvajerdi S; Zhu F; Fogarty CB; Fay MP; Fairhurst RM; Flegg JA; Stepniewska K; Small DS
Malar J; 2019 Jan; 18(1):4. PubMed ID: 30611278
[TBL] [Abstract][Full Text] [Related]
2. Quantification of parasite clearance in Plasmodium knowlesi infections.
T Thurai Rathnam J; Grigg MJ; Dini S; William T; Sakam SS; Cooper DJ; Rajahram GS; Barber BE; Anstey NM; Haghiri A; Rajasekhar M; Simpson JA
Malar J; 2023 Feb; 22(1):54. PubMed ID: 36782162
[TBL] [Abstract][Full Text] [Related]
3. Bayesian hierarchical regression on clearance rates in the presence of "lag" and "tail" phases with an application to malaria parasites.
Fogarty CB; Fay MP; Flegg JA; Stepniewska K; Fairhurst RM; Small DS
Biometrics; 2015 Sep; 71(3):751-9. PubMed ID: 25851174
[TBL] [Abstract][Full Text] [Related]
4. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator.
Flegg JA; Guerin PJ; White NJ; Stepniewska K
Malar J; 2011 Nov; 10():339. PubMed ID: 22074219
[TBL] [Abstract][Full Text] [Related]
5. A robust design for identification of the Parasite Clearance Estimator.
Jamsen KM; Duffull SB; Tarning J; Price RN; Simpson JA
Malar J; 2013 Nov; 12():410. PubMed ID: 24225256
[TBL] [Abstract][Full Text] [Related]
6. Malaria parasite clearance.
White NJ
Malar J; 2017 Feb; 16(1):88. PubMed ID: 28231817
[TBL] [Abstract][Full Text] [Related]
7. Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in mice.
Aogo RA; Khoury DS; Cromer D; Elliott T; Akter J; Fogg LG; Nair AS; Liligeto UN; Soon MSF; Thomas BS; Pernold CPS; Romanczuk AS; Laohamonthonkul P; Haque A; Davenport MP
Int J Parasitol; 2018 Oct; 48(12):903-913. PubMed ID: 30176235
[TBL] [Abstract][Full Text] [Related]
8. A menu-driven software package of Bayesian nonparametric (and parametric) mixed models for regression analysis and density estimation.
Karabatsos G
Behav Res Methods; 2017 Feb; 49(1):335-362. PubMed ID: 26956682
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of immune response and erythropoiesis during rodent malarial infection.
Miller MR; Råberg L; Read AF; Savill NJ
PLoS Comput Biol; 2010 Sep; 6(9):. PubMed ID: 20941388
[TBL] [Abstract][Full Text] [Related]
10. Comparison of statistical models to estimate parasite growth rate in the induced blood stage malaria model.
Wockner LF; Hoffmann I; O'Rourke P; McCarthy JS; Marquart L
Malar J; 2017 Aug; 16(1):352. PubMed ID: 28841864
[TBL] [Abstract][Full Text] [Related]
11. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN
Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860
[TBL] [Abstract][Full Text] [Related]
12. The parasite clearance curve.
White NJ
Malar J; 2011 Sep; 10():278. PubMed ID: 21939506
[TBL] [Abstract][Full Text] [Related]
13. Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs.
Simpson JA; Zaloumis S; DeLivera AM; Price RN; McCaw JM
AAPS J; 2014 Sep; 16(5):962-74. PubMed ID: 25056904
[TBL] [Abstract][Full Text] [Related]
14. Estimation of infection and recovery rates for highly polymorphic parasites when detectability is imperfect, using hidden Markov models.
Smith T; Vounatsou P
Stat Med; 2003 May; 22(10):1709-24. PubMed ID: 12720306
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a multiphasic parasite clearance profile after treatment of experimental human infection with the investigational anti-malarial M5717 using segmented mixed effect models.
Yin X; Li Y; Bagchus W; Yalkinoglu Ö; Bezuidenhout D; Tappert A; McCarthy J; Marquart L; Oeuvray C
Malar J; 2023 Jun; 22(1):199. PubMed ID: 37381013
[TBL] [Abstract][Full Text] [Related]
16. Estimation of heterogeneity in malaria transmission by stochastic modelling of apparent deviations from mass action kinetics.
Smith TA
Malar J; 2008 Jan; 7():12. PubMed ID: 18190717
[TBL] [Abstract][Full Text] [Related]
17. A Bayesian Approach for Summarizing and Modeling Time-Series Exposure Data with Left Censoring.
Houseman EA; Virji MA
Ann Work Expo Health; 2017 Aug; 61(7):773-783. PubMed ID: 28810680
[TBL] [Abstract][Full Text] [Related]
18. parallelMCMCcombine: an R package for bayesian methods for big data and analytics.
Miroshnikov A; Conlon EM
PLoS One; 2014; 9(9):e108425. PubMed ID: 25259608
[TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
20. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP
Int J Parasitol; 2017 Dec; 47(14):913-922. PubMed ID: 28864033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
